Summary

Sleep apnea is a sleeping disorder defined by an irregular breathing pattern during sleeping. Untreated sleep apnea deprives the brain and the rest of the body of oxygen, causing people to experience intermittent breathing while sleeping. Patients over the age of 65, as well as those suffering from diabetes, hypertension, cardiovascular disease, and other ailments, are more prone to have this condition. Obstructive sleep apnea (OSA) is the most common kind worldwide, and it requires early detection and treatment. The increased prevalence of obesity and other lifestyle problems in both industrialized and developing countries, as well as the rising rate of sleep apnea diagnosis, is creating a larger patient demography that requires sleep apnea treatment or management. This, together with the growing number of sleep physicians, technicians, and sleep clinics worldwide, is enabling the expansion of the global sleep apnea devices market. Healthy sleep is vital for excellent health, improved performance, and workplace safety. OSA strains the heart by repeatedly reducing oxygen levels and rising blood pressure while the patient sleeps. Severe sleep apnea, if left untreated, raises the chance of developing cardiac problems. As a result, non-profit groups, important businesses, and government agencies are sponsoring sleep apnea awareness programs. These promotional initiatives are intended at patients and healthcare professionals who treat insomnia and related secondary comorbidities, such as pulmonologists, sleep medicine specialists, primary care physicians, cardiologists, and neurologists. Manufacturers in the sleep apnea devices market are increasingly focusing on improving patient comfort to enhance treatment compliance. Innovations include more comfortable mask designs, quieter devices, and features that promote a better overall user experience. Home sleep testing (HST) has gained popularity as a convenient and cost-effective alternative to traditional in-laboratory sleep studies. Portable monitoring devices allow individuals to undergo sleep studies in the comfort of their own homes, facilitating broader access to diagnostic services.

According to the research report, “Global Sleep Apnea Devices Market Overview, 2023-28” published by Bonafide Research, the market is anticipated to cross USD 12 Billion by 2028, increasing from USD 5.03 Billion in 2022. The market is expected to grow with more than 7% CAGR by 2023-28. Several factors, including an extensive pool of undiagnosed individuals suffering from sleep apnea, rising use of oral appliances, and technological developments in sleep apnea devices, are fueling the worldwide sleep apnea market's expansion. Significant venture capital funding, as well as an increase in the number of firms participating in the sleep apnea and dental appliances sectors, are projected to boost market demand in the near future. Furthermore, the increasing prevalence of obstructive sleep apnea on a global scale is expected to drive sales of sleep apnea devices in the coming years. The global sleep apnea market is predicted to increase positively due to various potential benefits provided by mHealth and telemedicine in improving sleep apnea management and diagnosis. Numerous studies have found that patient adherence in the first few weeks of treatment is the most important predictor of long-term CPAP compliance. To advance compliance, follow-up and support must be prompt during this period. Telemedicine provides this type of assistance since long waiting lists make it difficult to provide this assistance. Many studies suggest that patients in the telemedicine group were very satisfied with their care and particularly liked the convenience of a live video contact with their doctor and consultant. Factors such as the high prevalence of sleep apnea, increasing potential risk factors, technological improvements in sleep apnea devices, and an aging population are all contributing to the growing sleep apnea devices market. Obstructive sleep apnea (OSA) is more common in adults with mild to moderate severity and is growing more common globally, thanks in part to the rising incidence of obesity. OSA is believed to affect one billion individuals worldwide, with frequency in some countries exceeding 50% of the overall population.

The evolution of Sleep Apnea Devices has been marked by significant advancements in technology, increased understanding of sleep disorders, and a growing awareness of the impact of sleep apnea on overall health. In the early stages, the primary treatment for sleep apnea involved surgical interventions to address anatomical issues causing airway obstruction. However, as research progressed, a shift toward non-invasive and more patient-friendly solutions emerged. One of the key milestones in the evolution of Sleep Apnea Devices is the development and widespread adoption of Continuous Positive Airway Pressure (CPAP) therapy. CPAP machines, which deliver a continuous stream of air to keep the airways open, became a breakthrough in the management of obstructive sleep apnea. Over time, these devices underwent improvements in terms of design, comfort, and functionality, enhancing patient compliance. The market also saw the introduction of Bi-level Positive Airway Pressure (BiPAP) machines, which provide varying levels of pressure for inhalation and exhalation, offering a more customized approach to therapy. Additionally, adaptive servo-ventilation devices were developed to dynamically adjust airway pressure based on individual breathing patterns during sleep. In recent years, there has been a trend toward the miniaturization and portability of sleep apnea devices, providing patients with more options for home-based therapy. Technological innovations, such as integrated data monitoring and connectivity features, allow healthcare providers to remotely monitor patient compliance and adjust treatment settings as needed. Furthermore, advancements in oral appliance therapy, which involves the use of devices worn in the mouth to reposition the jaw and tongue, have provided an alternative for individuals who may find traditional CPAP machines uncomfortable.

The Asia-Pacific region is experiencing significant growth in the Sleep Apnea Devices Market due to several factors. One key driver is the rising prevalence of sleep apnea in the region, attributed to lifestyle changes, increasing urbanization, and a growing aging population. As awareness about sleep disorders and their potential health implications expands, there is a corresponding increase in the diagnosis and treatment of sleep apnea. Moreover, improving healthcare infrastructure and a growing emphasis on healthcare quality are facilitating the adoption of advanced sleep apnea devices in the Asia-Pacific countries. Additionally, technological advancements in sleep apnea devices, such as continuous positive airway pressure (CPAP) machines, adaptive servo-ventilation devices, and oral appliances, are contributing to the market growth. Governments and healthcare organizations are also playing a role by implementing initiatives to address sleep disorders, thereby driving the demand for sleep apnea devices. The Sleep Apnea Devices Market in South America is experiencing growth due to several factors contributing to increased awareness, diagnosis, and treatment of sleep apnea in the region. A rising awareness of sleep disorders and their potential health implications has led to an uptick in individuals seeking medical assistance for sleep-related issues. As healthcare infrastructure in South America continues to improve, there is an enhanced capacity for the diagnosis and treatment of sleep apnea, driving the demand for sleep apnea devices. Additionally, lifestyle changes, urbanization, and a growing aging population contribute to the increasing prevalence of sleep apnea, further fueling the market growth. Governments and healthcare organizations in South America are also focusing on initiatives to address sleep disorders, including awareness campaigns and educational programs, fostering a more proactive approach to sleep health.

Sleeping masks, specifically referring to CPAP (Continuous Positive Airway Pressure) masks used in the treatment of sleep apnea, are experiencing growth in the Sleep Apnea Devices Market for various reasons. These masks are a crucial component of CPAP therapy, which is one of the primary and widely prescribed treatments for obstructive sleep apnea. As awareness about sleep disorders increases globally, more individuals are seeking diagnosis and treatment for conditions like sleep apnea. The effectiveness of CPAP therapy in alleviating symptoms such as snoring and improving sleep quality has contributed to the growing demand for CPAP masks. Technological advancements have also played a role in making these masks more user-friendly, comfortable, and customizable, enhancing patient compliance. Moreover, the rising prevalence of sleep apnea, coupled with a growing aging population, has led to an increased need for reliable and efficient sleep apnea devices, further propelling the market growth of sleeping masks within the broader Sleep Apnea Devices Market. The growth of Sleep Laboratories and Hospitals in the Sleep Apnea Devices Market is primarily attributed to the escalating prevalence of sleep disorders, particularly sleep apnea, and the increasing awareness of its potential health implications. Sleep laboratories and hospitals play a pivotal role in the diagnosis and treatment of sleep disorders by offering comprehensive sleep studies and evaluations. With a rising global emphasis on health and wellness, individuals are seeking medical assistance for sleep-related issues, leading to an upsurge in the number of patients diagnosed with sleep apnea. The availability of advanced diagnostic technologies and expertise in sleep medicine within sleep laboratories and hospitals makes them key contributors to the market growth. Additionally, healthcare professionals in these settings are increasingly recognizing the importance of integrating sleep apnea management into broader healthcare practices, fostering the demand for sleep apnea devices. As a result, the collaborative efforts of sleep laboratories and hospitals are pivotal in driving the expansion of the Sleep Apnea Devices Market, ensuring effective diagnosis, treatment, and management of sleep apnea for improved patient outcomes.

Market Drivers

• Increased Awareness and Diagnosis: Growing awareness about the health consequences of untreated sleep apnea has led to an increase in the number of individuals seeking diagnosis and treatment. Healthcare professionals are increasingly recognizing the importance of identifying and addressing sleep disorders, contributing to the demand for sleep apnea diagnostic devices.

• Rising Healthcare Expenditure: The overall increase in healthcare spending, particularly in developed economies, can positively influence the sleep apnea devices market. As governments and private healthcare entities invest in improving diagnostic and therapeutic capabilities, there is a potential for expanded access to sleep apnea devices and services.

Market Challenges

• Complexity of Diagnosis and Treatment: Diagnosing and treating sleep apnea can be complex due to the variety of factors contributing to the disorder. The need for specialized expertise in sleep medicine and the interpretation of sleep studies can pose challenges. Streamlining and simplifying diagnostic processes and treatment pathways can improve overall patient outcomes.

• Limited Reimbursement Policies: Reimbursement policies and coverage for sleep apnea devices and related services can vary widely across different regions. In some cases, limited or inconsistent reimbursement may hinder patient access to necessary devices and treatments. Establishing more comprehensive and standardized reimbursement policies is essential for market growth.

Market Trends

• Personalized Medicine and Customization: There is a growing emphasis on personalized medicine in the sleep apnea devices market. Tailoring treatment plans and device settings to individual patient needs and preferences can improve overall compliance and treatment efficacy. Customization of devices, such as adjustable pressure settings in CPAP machines, is a trend that aligns with the goal of providing more patient-centric care.

• Collaborations and Partnerships: Collaborations between healthcare providers, technology companies, and manufacturers are becoming more common. These partnerships aim to combine expertise in sleep medicine, data analytics, and device manufacturing to create comprehensive solutions for sleep apnea diagnosis and management.

Covid-19 Impacts

The pandemic has disrupted global supply chains, affecting the manufacturing and distribution of medical devices, including sleep apnea devices. Lockdowns, travel restrictions, and changes in demand for healthcare resources have led to challenges in the production and delivery of these devices. Due to the pandemic, individuals have postponed or avoided seeking medical attention for non-urgent health issues, including sleep-related disorders. This delay in diagnosis and treatment could impact the demand for sleep apnea devices, as patients not have been identified and prescribed appropriate therapies during the height of the pandemic. The pandemic has accelerated the adoption of telemedicine and remote monitoring solutions across various healthcare sectors. Sleep apnea patients, in particular, have sought virtual consultations and remote monitoring options to avoid in-person visits to healthcare facilities. This trend could influence the development and adoption of sleep apnea devices with enhanced connectivity features. Economic challenges resulting from the pandemic have affected individuals' ability to afford healthcare services and devices. This economic impact could influence the purchasing decisions of sleep apnea patients, potentially leading to shifts in demand for different types of devices or preferences for more cost-effective solutions. The heightened awareness of respiratory health during the COVID-19 pandemic has increased attention to sleep-related breathing disorders. Healthcare providers and patients alike are more attuned to symptoms of sleep apnea, potentially driving increased diagnoses and treatment once healthcare services returned to a more normalized state. With the widespread adoption of remote work during the pandemic, changes in work schedules and lifestyles have influenced sleep patterns. These shifts could impact the prevalence of sleep disorders, including sleep apnea, and subsequently, the demand for diagnostic and therapeutic devices.

Competitive Landscape

The key players are constantly focusing on innovative product development strategies to gain a competitive edge and expand their business footprints. The companies are devising merger & acquisitions and partnership strategies to expand their product offering and serve the growing customer pool. For instance, in February 2021, Nyxoah SA and Vanderbilt University entered a strategic partnership to develop innovative neurostimulation solutions for treating OSA. Prominent companies in this market include well-established, financially stable manufacturers of diagnostic and therapeutic sleep apnea devices. These sleep apnea companies have been operating in the market for several years and possess a diversified product portfolio, state-of-the-art technologies, and strong global sales and marketing networks. Prominent sleep apnea companies in this market include ResMed Inc. , Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., GE HealthCare Technologies, Inc., BMC Medical Co Ltd, Invacare Corporation , Itamar Medical Ltd, Compumedics Ltd, Drive DeVilbiss Healthcare, Nihon Kohden Corporation, LivaNova, PLC , Airway Management Inc.,, Rotech Healthcare Inc, Nyxoah SA, Cardinal Health, Inc, Drägerwerk AG & Co. KGaA, Inspire Medical Systems, Inc and SomnoMed Limited.

Key Developments

• In April 2022, Fisher & Paykel Healthcare announced the launch of the F&P Evora Full in the US, a compact full-face mask for OSA.
• In June 2021, Oventus Medical signed a partnership agreement with Aeroflow Healthcare to bring Oventus' OSA treatment solutions, including O2Vent Optima, directly to consumers through US sleep clinics.
• In August 2021, ResMed launched a new PAP device in the US sleep apnea devices market to help hundreds of millions of people with sleep apnea.
• In February 2021, Oventus Medical launched 02Vent Optima, a customizable oral appliance therapy device that offers an alternative to CPAP therapy through GoPAPfree in the US.

Considered in this report:

• Geography: Global
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• Global Sleep Apnea Devices market with its value and forecast along with its segments
• Region-wise Sleep Apnea Devices market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Regions covered in the report

• North America
• Europe
• Asia-Pacific
• South America
• Middle-East & Africa

By Product:

• Positive Airway Pressure (PAP) Devices
• Adaptive Servo-Ventilation (ASV)
• Airway Clearance Systems
• Oxygen Delivery Products
• Oral Appliances
• Others

By End User:

• Home care Settings & Individuals
• Sleep laboratories & Hospitals

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Sleep Apnea Therapeutic Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.



***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents